New study highlights a gut pathway for red wine compound resveratrol
08 April 2016
For years now resveratrol, a compound found in red wine, has intrigued and confounded researchers. It has repeatedly been linked to antiaging benefits, demonstrating antiatherosclerosis effects in animal studies and inspiring a $720 million buyout at GlaxoSmithKline.
Once again, Pharma beats all other industries with $1.5B in magazine ads
07 April 2016
Pharma spending on magazine ads jumped to more than $1.53 billion in 2015, according to data provided by Nielsen. That's an increase of 19% from $1.29 million in 2014. The prescription drug category also once again led all other ad categories when it comes to magazines--ahead of consumer categories such as fashion and skin care--and widened its lead to boot.
The tradeoffs: Personalized treatment vs. one-size-fits-all standards
07 April 2016
What would happen if instead of a personalized treatment plan your doctor used a one-size-fits-all standard of care?
New leadership, funding set to boost Taiwan's biopharma industry
06 April 2016
In recent years, Taiwan has been pouring considerable attention, effort and funding into the development of a sustainable biotech industry, seeking a new economic driver to replace the diminishing prominence of its once-dominant electronics manufacturing sector.
China initiative would pour billions into precision medicine
06 April 2016
As part of an effort to step up as a precision medicine powerhouse, the Chinese government is moving forward on an initiative that would see it provide billions of dollars in funding over the next 15 years.
Drug shortages prompt question: are some medicines too cheap?
06 April 2016
Philip Aubrey buys medicines for British government-funded hospitals across London, capital of the world's fifth-largest economy, but last year he struggled to secure supplies of a basic AIDS drug.
Smallest genomed-bacterium addresses big questions
06 April 2016
Among the insights to be had from the "minimal genome" cell that was reported Thursday is just how relative the term minimal is – a fact freely acknowledged by its creators.
Research primes pipeline with drug candidates aimed at CF
05 April 2016
In the U.S., about 1,000 new cases of cystic fibrosis (CF) – the rare, life-threatening genetic disease that causes persistent lung infections and progressively limits the ability to breathe – are diagnosed each year, according to the Cystic Fibrosis Foundation. While there are effective therapies that target the symptoms, there are no treatments that will fully restore lung function. However, genomic research is concentrating on a better understanding of the mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in order to develop the next generation of therapies aimed at ameliorating the underlying genetic causes of CF.
Europe gives green light to first gene therapy for children
05 April 2016
The world's first life-saving gene therapy for children, developed by Italian scientists and GlaxoSmithKline, has been recommended for approval in Europe, boosting the pioneering technology to fix faulty genes.
FDA publishes more biosimilar labeling advice after pharma voices its concerns
05 April 2016
The FDA has released further draft guidelines on how biopharma should label their new copycat biologics in what has been described as a "positive for the biosimilars industry," but problems over interchangeability remain.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024